Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Petersen

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 4, 2003
Switching to bupropion in fluoxetine-resistant major depressive disorderMaurizio Fava, George I Papakostas, Timothy Petersen, et al.
Psychiatry Research|December 13, 2006
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorderGeorge I Papakostas, Timothy Petersen, Katherine G Sklarsky, et al.
Psychiatry Research|May 26, 2004
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorderGeorge I Papakostas, Timothy Petersen, Megan E Hughes, et al.
Psychotherapy and Psychosomatics|September 11, 2002
Treatment-resistant depression and Axis II comorbidityTimothy Petersen, Megan Hughes, George I Papakostas, et al.
Psychiatry Research|February 19, 2002
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatientsTimothy Petersen, George I Papakostas, Kathryn Bottonari, et al.
The Journal of Surgical Research|September 5, 2021
Use of Erector Spinae Fascial Plane Blocks in Enhanced Recovery for Open Abdominal SurgeryAlissa Greenbaum, Hannah Wilcox, Christine H Teng, et al.
The Journal of Clinical Psychiatry|July 20, 2006
Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetineGeorge I Papakostas, Karen K Miller, Timothy Petersen, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 25, 2007
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy Petersen, Caitlin H Homberger, et al.
International Clinical Psychopharmacology|August 16, 2003
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsedGeorge I Papakostas, Timothy Petersen, John J Worthington, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 20, 2004
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorderGeorge I Papakostas, Timothy Petersen, John W Denninger, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 4, 2003
Switching to bupropion in fluoxetine-resistant major depressive disorderMaurizio Fava, George I Papakostas, Timothy Petersen, et al.
Psychiatry Research|December 13, 2006
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorderGeorge I Papakostas, Timothy Petersen, Katherine G Sklarsky, et al.
Psychiatry Research|May 26, 2004
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorderGeorge I Papakostas, Timothy Petersen, Megan E Hughes, et al.
Psychotherapy and Psychosomatics|September 11, 2002
Treatment-resistant depression and Axis II comorbidityTimothy Petersen, Megan Hughes, George I Papakostas, et al.
Psychiatry Research|February 19, 2002
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatientsTimothy Petersen, George I Papakostas, Kathryn Bottonari, et al.
The Journal of Surgical Research|September 5, 2021
Use of Erector Spinae Fascial Plane Blocks in Enhanced Recovery for Open Abdominal SurgeryAlissa Greenbaum, Hannah Wilcox, Christine H Teng, et al.
The Journal of Clinical Psychiatry|July 20, 2006
Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetineGeorge I Papakostas, Karen K Miller, Timothy Petersen, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 25, 2007
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy Petersen, Caitlin H Homberger, et al.
International Clinical Psychopharmacology|August 16, 2003
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsedGeorge I Papakostas, Timothy Petersen, John J Worthington, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 20, 2004
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorderGeorge I Papakostas, Timothy Petersen, John W Denninger, et al.
Pageof 6